Perspectives on gene therapy in the treatment of ocular inflammation

Eye

Volumn 11, Issue 2, 1997, Pages 217-221

  Nussenblatt, Robert B ^a   Csaky, Karl ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b NONE

Author keywords

Autoimmune disease; Gene therapy; Ocular disease; Uveitis

Indexed keywords

CONFERENCE PAPER; DRUG DELIVERY SYSTEM; EXPRESSION VECTOR; EYE DISEASE; EYE INFLAMMATION; GENE EXPRESSION; GENE INSERTION; GENE THERAPY; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; GENOME; HUMAN; METHODOLOGY; PATHOGENESIS; RETINA GYRATE ATROPHY; TRANSGENE;

EID: 0030989387     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1997.55     Document Type: Conference Paper

References (17)

1. Wang T, Milam AH, Steel G, Valle D. A mouse model of gyrate atrophy of the choroid and retina. J Clin Invest 1996;97:2753-62.
2. Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors. Curr Opin Genet Dev 1993;3:499-503.
3. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994;91: 6196-200.
4. Morgan RA, Anderson WF. Human gene therapy. Annu Rev Biochem 1993;62:191-217.
5. Cornetta K, Morgan RA, Anderson WF. Safety issues related to retroviral-mediated gene transfer in humans Hum Gene Ther 1991;2:5-14.
6. Kaiser-Kupfer M, Caruso R, Valle D. Gyrate atrophy of the choroid and retina: chronic reduction of ornithine slows retinal degeneration. Arch Ophthalmol 1991;109:1539-48.
7. Vogel JC. Keratinocyte gene therapy. Arch Dermatol 1993;129:1478-83.
8. Sullivan DM, Chung DC, Anglade E, Nussenblatt RB, Csaky KG. Adenovirus-mediated gene transfer of ornithine aminotransferase in cultured human retinal pigment epithelium. Invest Ophthalmol Vis Sci 1996;37:766-74.
9. Bennett J, Wilson J, Sun D, Forbes B, Maguire A. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci 1994;35:2535-42.
10. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270: 1189-92.
11. Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991;53:411-4.
12. Unoki K, LaVail MM. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci 1994;35:907-15.
13. Blau HM, Springer ML. Gene therapy: a novel form of drug therapy. N Engl J Med 1995;333:1204-7.
14. Papavassiliou AG. Transcription factors. N Engl J Med 1995;332:45-7.
15. Egwuagu CE, Sztein J, Reid W, et al. Gamma Interferon gene expression in the lens of transgenic mice directed by the alpha-A-crystallin gene promoter Invest Ophthalmol Vis Sci 1992;33:846.
16. Egwuagu CE, Sztein J, Chan CC, et al. Gamma interferon expression disrupts lens and retinal differentiation in transgenic mice. Dev Biol 1994;166: 557-68.
17. Egwuagu CE, Mahdi R, Smith JA, Chan CC, Chepelinsky AB. Gamma interferon-expressing transgenic rats: a useful model of anterior and posterior uveitis. Invest Ophthalmol Vis Sci 1996;37(Suppl): 4229.